239 related articles for article (PubMed ID: 30112668)
1. Acquired drug-induced long QTc: new insights coming from a retrospective study.
De Vecchis R; Ariano C; Di Biase G; Noutsias M
Eur J Clin Pharmacol; 2018 Dec; 74(12):1645-1651. PubMed ID: 30112668
[TBL] [Abstract][Full Text] [Related]
2. Malignant Ventricular Arrhythmias Resulting From Drug-Induced QTc Prolongation: A Retrospective Study.
De Vecchis R; Ariano C; Di Biase G; Noutsias M
J Clin Med Res; 2018 Jul; 10(7):593-600. PubMed ID: 29904445
[TBL] [Abstract][Full Text] [Related]
3. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
4. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
5. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.
Darbar D; Kimbrough J; Jawaid A; McCray R; Ritchie MD; Roden DM
J Am Coll Cardiol; 2008 Feb; 51(8):836-42. PubMed ID: 18294569
[TBL] [Abstract][Full Text] [Related]
6. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
[TBL] [Abstract][Full Text] [Related]
7. Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.
Chorin E; Hochstadt A; Viskin S; Rozovski U; Havakuk O; Baranchuk A; Enriquez A; Strasberg B; Guevara-Valdivia ME; Márquez MF; González-Pacheco H; Hasdemir C; Rosso R
Heart Rhythm; 2017 Jan; 14(1):90-95. PubMed ID: 27650425
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram.
Chan A; Isbister GK; Kirkpatrick CM; Dufful SB
QJM; 2007 Oct; 100(10):609-15. PubMed ID: 17881416
[TBL] [Abstract][Full Text] [Related]
9. Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents.
Jardin CG; Putney D; Michaud S
Ann Pharmacother; 2014 Feb; 48(2):196-202. PubMed ID: 24301687
[TBL] [Abstract][Full Text] [Related]
10. Utility of QT interval corrected by Rautaharju method to predict drug-induced torsade de pointes.
Othong R; Wattanasansomboon S; Kruutsaha T; Chesson D; Arj-Ong Vallibhakara S; Kazzi Z
Clin Toxicol (Phila); 2019 Apr; 57(4):234-239. PubMed ID: 30260244
[TBL] [Abstract][Full Text] [Related]
11. Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.
Vieweg WV; Hasnain M; Hancox JC; Baranchuk A; Digby GC; Kogut C; Crouse EL; Koneru JN; Deshmukh A; Pandurangi AK
Psychopharmacology (Berl); 2013 Aug; 228(4):515-24. PubMed ID: 23812796
[TBL] [Abstract][Full Text] [Related]
12. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
Othong R; Devlin JJ; Kazzi ZN
Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
[TBL] [Abstract][Full Text] [Related]
13. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic Parameters Indicating Worse Evolution in Patients with Acquired Long QT Syndrome and Torsades de Pointes.
Kukla P; Jastrzębski M; Fijorek K; Stec S; Bryniarski L; Czarnecka D; Baranchuk A
Ann Noninvasive Electrocardiol; 2016 Nov; 21(6):572-579. PubMed ID: 27018992
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive cardiac activation imaging of ventricular arrhythmias during drug-induced QT prolongation in the rabbit heart.
Han C; Pogwizd SM; Killingsworth CR; Zhou Z; He B
Heart Rhythm; 2013 Oct; 10(10):1509-15. PubMed ID: 23773986
[TBL] [Abstract][Full Text] [Related]
16. QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes".
Ryan K; Benz P; Zosel A; Farkas A; Theobald J
Cardiovasc Toxicol; 2022 Sep; 22(9):866-877. PubMed ID: 35930218
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
Haddad PM; Anderson IM
Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
[TBL] [Abstract][Full Text] [Related]
18. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.
Drici MD; Clément N
Drug Saf; 2001; 24(8):575-85. PubMed ID: 11480490
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors.
Letsas KP; Efremidis M; Kounas SP; Pappas LK; Gavrielatos G; Alexanian IP; Dimopoulos NP; Filippatos GS; Sideris A; Kardaras F
Clin Res Cardiol; 2009 Apr; 98(4):208-12. PubMed ID: 19031039
[TBL] [Abstract][Full Text] [Related]
20. Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome.
Wang M; Szepietowska B; Polonsky B; McNitt S; Moss AJ; Zareba W; Auerbach DS
Am J Cardiol; 2018 Jan; 121(2):182-187. PubMed ID: 29174490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]